Bharat Biotech Chairperson Krishna Ella on Monday hit back at those criticising the granting of emergency use approval to its coronavirus vaccine candidate, saying that the vaccine was safe and the firm has conducted “200% honest clinical trials,” reported PTI.
Drugs Controller General of India had on Sunday approved Covaxin, Bharat Biotech’s vaccine candidate, for restricted emergency use. Various critics, including the Congress, had raised questions on the approval as the company has not published the efficacy data for the vaccine.
“Give me one week’s time, I will give you confirmed data,” Ella said, speaking at a virtual press conference. The biotechnology company chief said that his firm has a track record of producing safe and efficacious vaccines and was transparent with all data. Bharat Biotech has manufactured 16 vaccines, he said.
“We are not just conducting clinical trials in India. We have done clinical trials in more than 12 countries including the…